Page 371 - AIDSBK23C
P. 371

Page 371




               907     Grinspoon SK. Metabolic syndrome and cardiovascular disease in patients with human
                       immunodeficicency virus. Am J Med. 2005;118(Suppl 2):23S-28S.

               908     van Wijk JP, de Koning EJ, Cabezas MC, Joven J, op't Roodt J, Rabelink TJ, Hoepelman
                       AM. Functional and structural markers of atherosclerosis in human immunodeficiency
                       virus-infected patients. J Am Coll Cardiol. 2006;47:1117-1123.

               909     Thomas CM, Smart EJ. How HIV protease inhibitors promote atherosclerotic lesion
                       formation. Curr Opin Lipidol. 2007;18:561-565.

               910     Eugenin EA, Morgello S, Klotman ME, Mosoian A, Lento PA, Berman JW, Schecter
                       AD. Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in
                       vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease.
                       Am J Pathol. 2008;172:1100-1111.

               911     Duong M, Buisson M, Cotin Y, et al. Coronary heart disease associated with the use of
                       human immunodeficiency virus (HIV)-1 protease inhibitors: report of four cases and
                       review. Clin Cardiol. 2001;24:690-694.

               912     Periard D, Cavassini M, Taffé P, Chevalley M, Senn L, Chapuis-Taillard C, deVallière S,
                       Hayoz D, Tarr PE. High prevalence of peripheral arterial disease in HIV-infected
                       persons. Clin Infect Dis. 2008;46:761-767.

               913     Depairon M, Chessex S, Sudre P, et al. Premature atherosclerosis in HIV-infected
                       individuals—focus on protease inhibitor therapy. AIDS. 2001;15:329-334.

               914     Monsuez JJ, Charniot JC, Escaut L, Teicher E, Wyplosz B, Couzigou C, Vignat N, et al.
                       HIV-associated vascular diseases: structural and functional changes, clinical implications.
                       Int J Cardiol. 2009;133:293-306.

               915     Guillevin L. Vasculitides in the context of HIV infection. AIDS. 2008;22(Suppl 3):S27-
                       33.

               916     Patel N, Patel N, Khan T, Patel N, Espinoza LR. HIV infection and clinical spectrum of
                       associated vasculitides. Curr Rheumatol Rep. 2011;13(6):506-512.

               917     Chetty R, Batitang S, Nair R. Large artery vasculopathy in HIV-positive patients: another
                       vasculitic enigma. Hum Pathol. 2000;31:374-379.

               918     DiCarlo FJ, Anderson DW, Virmani R, et al. Rheumatic heart disease in a patient with
                       acquired immunodeficiency syndrome. Hum Pathol. 1989;20:917-920.

               919     Shindel AW, Akhavan A, Sharlip ID. Urologic aspects of HIV infection. Med Clin North
                       Am. 2011;95:129-151.
   366   367   368   369   370   371   372   373   374   375   376